Opko Health (OPK) Return on Capital Employed (2011 - 2026)

Opko Health has reported Return on Capital Employed for 15 years, with the latest figure at 1.98% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 1234.0% year-over-year to 1.98%; the trailing twelve-month figure through Mar 2026 stood at 1.98% (up 1234.0% YoY), and the FY2025 full-year result was 2.64%, up 538.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 1.98%, up from 2.79% in the prior quarter.
• The five-year high for Return on Capital Employed was 1.98% in Q1 2026, with the low at 15.17% in Q2 2024.
• Historically, Return on Capital Employed has averaged 9.24% across 5 years, with a median of 9.04% in 2023.
• Annual changes were most pronounced in 2022 — Return on Capital Employed plunged 1767 bps — and 2026, when it surged 1234 bps.
• Opko Health's Return on Capital Employed stood at 11.41% in 2022, then gained by 25 bps to 8.56% in 2023, then sank by 65 bps to 14.13% in 2024, then surged by 80 bps to 2.79% in 2025, then climbed by 29 bps to 1.98% in 2026.
• The last three Return on Capital Employed figures came in at 1.98% (Q1 2026), 2.79% (Q4 2025), and 8.06% (Q3 2025), per Business Quant data.